bluebird bio (BLUE) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free BLUE Stock Alerts $1.03 -0.02 (-1.90%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 5:32 PM | businesswire.comBLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitMay 16 at 4:45 PM | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitMay 16 at 9:22 AM | fool.comIs Bluebird Bio Stock a Buy?May 15, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmMay 15, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming DeadlineMay 14, 2024 | prnewswire.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUEMay 14, 2024 | prnewswire.comClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law FirmMay 13, 2024 | businesswire.comBLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitMay 13, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitMay 13, 2024 | prnewswire.comShareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMay 11, 2024 | seekingalpha.combluebird bio, Inc. (BLUE) Q1 2024 Earnings Call TranscriptMay 11, 2024 | americanbankingnews.combluebird bio, Inc. (NASDAQ:BLUE) Receives Consensus Rating of "Hold" from AnalystsMay 10, 2024 | msn.combluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.combluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...May 9, 2024 | msn.combluebird bio reports Q1 resultsMay 9, 2024 | finance.yahoo.combluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceMay 8, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitMay 8, 2024 | prnewswire.comMay 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUEMay 7, 2024 | prnewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEMay 7, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmMay 7, 2024 | marketbeat.combluebird bio (BLUE) Scheduled to Post Earnings on Thursdaybluebird bio (NASDAQ:BLUE) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 7, 2024 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUEMay 6, 2024 | bizjournals.comFirst sickle cell patient begins bluebird gene therapy treatmentMay 6, 2024 | businesswire.combluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor EventsMay 6, 2024 | businesswire.combluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene TherapyMay 6, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming DeadlineMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueMay 3, 2024 | prnewswire.comClass Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law FirmMay 3, 2024 | msn.comSweetwater's big fourth inning carries them past Polk CountyMay 2, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitMay 1, 2024 | markets.businessinsider.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEMay 1, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmApril 30, 2024 | marketbeat.comShort Interest in bluebird bio, Inc. (NASDAQ:BLUE) Grows By 9.6%bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 32,620,000 shares, an increase of 9.6% from the March 31st total of 29,750,000 shares. Based on an average daily trading volume, of 8,500,000 shares, the days-to-cover ratio is currently 3.8 days.April 29, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitApril 29, 2024 | prnewswire.comBLUE INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUEApril 27, 2024 | prnewswire.comBLUE INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEApril 27, 2024 | markets.businessinsider.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bioApril 27, 2024 | stockhouse.comBLUE LOSS ALERT: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEApril 26, 2024 | businesswire.combluebird bio Announces Receipt of Expected Notice from NasdaqApril 26, 2024 | prnewswire.comBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineApril 26, 2024 | prnewswire.comBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineApril 25, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueApril 24, 2024 | stockhouse.comBLUE Equity Alert: ROSEN, A Top Ranked Law Firm, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEApril 24, 2024 | prnewswire.comBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud LawsuitApril 23, 2024 | money.usnews.comBluebird bio IncApril 23, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmApril 22, 2024 | prnewswire.comLost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyApril 21, 2024 | markets.businessinsider.comROSEN, National Trial Lawyers, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Bitcoin: This $8 Stock Is the Next Big Thing (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> BLUE Media Mentions By Week BLUE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLUE News Sentiment▼0.020.43▲Average Medical News Sentiment BLUE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLUE Articles This Week▼106▲BLUE Articles Average Week Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sangamo Therapeutics News Today Gritstone bio News Today Outlook Therapeutics News Today aTyr Pharma News Today Omega Therapeutics News Today Vigil Neuroscience News Today Passage Bio News Today Curis News Today DBV Technologies News Today AlloVir News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLUE) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
